Video Shorts

1:16
Market Movers RX: Moderna's Bounce Back
2 days ago
by
Nicholas Jacobus

1:03
Closing the R&D-to-Manufacturing Handoff
4 days ago
by
Michael Christel(+1 more)

1:02
The Constraints of Midsize Pharma
4 days ago
by
Mike Hollan(+1 more)

1:04
Beyond the Midterms: States Driving Pharma Policy Debate
6 days ago
by
Michael Christel(+1 more)

0:47
Retiring the Term Digital Twin for Digital Clones
6 days ago
by
Mike Hollan(+1 more)

1:27
What's Shifting and What's Staying the Same
13 days ago
by
Mike Hollan

1:14
Market Movers RX: Car Zeiss Meditec Leads Gainers
16 days ago
by
Nicholas Jacobus

0:42
Is Your Infrastructure Ready for AI Tools
18 days ago
by
Mike Hollan(+1 more)

1:03
Biotech’s Education Mandate
24 days ago
by
Michael Christel(+2 more)

1:07
The Next Generation of Obesity Treatment Challenges
25 days ago
by
Mike Hollan(+1 more)

1:11
Market Movers RX: Pacific Biosciences Leads Gainers
a month ago
by
Nicholas Jacobus

1:07
The Hidden Cost of Self-Reported Patient Data
a month ago
by
Mike Hollan(+1 more)

0:48
Why Connecting Talent is the Key to Scaling Business
a month ago
by
Mike Hollan(+1 more)

1:09
Filling the Gaps in Digital Health and Care Navigation
a month ago
by
Mike Hollan(+1 more)

1:17
Market Movers RX: Moderna & Roche Top Gainers
a month ago
by
Nicholas Jacobus

1:12
Why Your Diabetes and Obesity Meds Might Not Be Working
2 months ago
by
Mike Hollan(+1 more)

1:18
Exec on Execs: Pharma Pricing's Regulatory Status
2 months ago
by
Mike Hollan

0:42
Why Executive Orders Won't Fix Drug Prices
2 months ago

1:20
Market Movers RX: West Pharmaceutical Services Leads Gainers
2 months ago
by
Nicholas Jacobus

1:10
The Evolution and Future of IBD Treatments
2 months ago
by
Mike Hollan(+1 more)

1:41
Exec on Execs: The Changing Data Environment
2 months ago
by
Mike Hollan

1:21
Market Movers Rx: Belite Bio Leads Gainers
2 months ago
by
Nicholas Jacobus

0:50
Unlocking the Future of Real-World Data & Research
2 months ago
by
Mike Hollan(+1 more)

1:42
Exec on Execs: Persistent Unmet Needs
2 months ago
by
Mike Hollan

1:18
Pharma 50: The Trends Behind the Numbers
2 months ago
by
Michael Christel

1:28
Market Movers RX: Regeneron and McKesson Lead Gainers
2 months ago
by
Nicholas Jacobus

0:51
The Secret Equation for AI Trust
2 months ago
by
Mike Hollan(+1 more)

0:41
Why Patients Will Use Peptides Regardless of FDA Status
2 months ago
by
Nicholas Jacobus(+1 more)

1:31
Exec on Execs: Compliance Burdens
2 months ago
by
Mike Hollan
Advertisement
Advertisement
Trending on PharmExec
1
Hims & Hers Partners with Eli Lilly to Sell Obesity Medicines
2
Pharmaceutical Executive Daily: FDA Grants Accelerated Approval to Rybrevant Faspro
3
The US Drug-Pricing Reset: Competing on Net Value
4
Roundup: Boehringer Ingelheim Licenses Six Oncology Programs From Sino Biopharmaceutical, Nxera Licenses EP4 Agonist to AbbVie
5

